Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system. CF causes the body to produce thick, sticky mucus that leads to progressive lung infection and difficulty gaining weight.
Cystic fibrosis (CF) is an inherited disease characterized by an abnormality in the glands that produce sweat and mucus. Due to improved treatments, people with CF, on average, live into their mid to late 30s.
Cystic fibrosis affects various organ systems in children and young adults, including the following:
There are about 30,000 people in the U.S. who are affected with cystic fibrosis. It occurs mainly in Caucasians of northern European ancestry, although African-Americans, Asian Americans, and Native Americans may have the disease as well.
Approximately one in 31 people in the U.S. are carriers of the cystic fibrosis gene. These people are not affected by the disease and usually do not know that they are carriers.
The basis for the problem with CF lies in an abnormal gene. The result of this gene defect is an atypical electrolyte transport system within the cells of the body. Electrolytes are substances in blood that are critical to cell function. The abnormal transport system in CF causes the cells in the respiratory system, especially the lungs, to absorb too much sodium and water. This causes the normal thin secretions in our lungs to become very thick and hard to remove. These thick secretions put the child with CF at risk for frequent respiratory infections.
Recurrent respiratory infections lead to progressive damage in the lungs, and eventually death of the cells in the lungs. The most common causes for infection in the lungs of the CF patient are the following bacteria:
Pseudomonas aeruginosa (PA)
PA is the most common bacteria that causes infection and can be difficult to fight with standard antibiotics.
As a result of the high rate of infection in the lower respiratory tract, people with CF may develop a chronic cough, blood in the sputum, and even have a collapsed lung. The cough is usually worse in the morning or after activity.
People with CF also experience upper respiratory tract symptoms. Some patients have nasal polyps that require surgical removal. Nasal polyps are small protrusions of tissue from the lining of the nose that can obstruct and irritate the nasal cavity. Children with CF may also have a higher rate of sinus infections.
The organ primarily affected is the pancreas, which secretes substances that aid digestion and help control blood-glucose levels.
As a result of the abnormal electrolyte transport system in the cells, the secretions from the pancreas become thick and can lead to obstruction of the ducts of the pancreas. This obstruction may cause a decrease in the secretion of enzymes from the pancreas that normally help to digest food. A person with CF has difficulty absorbing proteins, fats, and vitamins A, D, E, and K.
The problems with the pancreas can become so severe that some of the cells in the pancreas are destroyed. This may lead to glucose intolerance and insulin-dependent diabetes. About 35 percent of CF patients develop this type of diabetes in their 20s and about 40 percent develop the disease after 30 years of age.
The symptoms that may be present due to the involvement with the GI tract include the following:
Bulky, greasy stools
Rectal prolapse. A condition in which the end part of the bowels comes out of the anus.
Fat in the stools
The liver may also be affected. A small number of patients may actually develop liver disease. Symptoms of liver disease may include:
Yellow color to the skin
Vomiting of blood
Most males with CF have obstruction of the sperm canal known as congenital bilateral absence of the vas deferens (CBAVD). This results from the abnormal electrolyte transport system in the cells, causing the secretions to become thick and may lead to obstruction and even infertility. Women also have an increase in thick cervical mucus that may lead to a decrease in fertility, although many women with CF are able to have children.
The following are the most common symptoms of cystic fibrosis. However, individuals may experience symptoms differently. Symptoms may include:
Abnormalities in the glands that produce sweat and mucus. This may cause a loss of salt. A loss of salt may cause an upset in the balance of minerals in the blood, abnormal heart rhythms, and, possibly, low blood pressure and shock.
Thick mucus that accumulates in the lungs and intestines. This may cause malnutrition, poor growth, frequent respiratory infections, breathing difficulties, and chronic lung disease.
Other medical problems, such as:
Clubbing of fingers and toes. A condition marked by extremely thickened fingertips and toes due to decreased oxygen in the blood.
Pneumothorax. Collapse of the lung often due to intense coughing.
Hemoptysis. Coughing up blood.
Cor pulmonale. Enlargement of the right side of the heart due to increased pressure in the lungs.
Excess gas in the intestines
Pancreatitis. Inflammation of the pancreas that causes severe abdominal pain.
Congenital bilateral absence of the vas deferens (CBAVD) in males
As stated above, the symptoms of CF differ for each person. Infants born with CF usually show symptoms by age two. Some children, though, may not show symptoms until later in life. The following signs are suspicious of CF, and infants having these signs may be tested for CF:
Diarrhea that does not go away
Frequent episodes of wheezing
Frequent episodes of pneumonia or other lung infections
Skin tastes like salt
Poor growth despite a good appetite
The symptoms of cystic fibrosis may resemble other conditions or medical problems. Consult a doctor for a diagnosis.
Most cases of cystic fibrosis are now identified with newborn screening. In addition to a complete medical history and physical examination, diagnostic procedures for cystic fibrosis include a sweat test to measure the amount of sodium chloride (salt) present. Higher than normal amounts of sodium and chloride suggest cystic fibrosis. Other diagnostic procedures include:
Lung function tests
For babies, who do not produce enough sweat, blood tests may be used.
Specific treatment for cystic fibrosis will be determined by your doctor based on:
Your age, overall health, and medical history
Extent of the disease
Expectations for the course of the disease
Your tolerance for specific medications, procedures, or therapies
Your opinion or preference
Currently, there is no cure for CF. A cure would call for gene therapy at an early age and this has not been developed yet, although research is being done in this direction. The gene that causes CF has been identified and there are hopes that this will lead to an increased understanding of the disease. Also being researched are different drug regimens to help stop CF. Goals of treatment are to ease severity of symptoms and slow the progress of the disease. Treatment may include:
Management of problems that cause lung obstruction, which may involve:
Exercise to loosen mucus, stimulate coughing, and improve overall physical condition
Medications to reduce mucus and help breathing
Antibiotics to treat infections
Management of digestive problems, which may involve:
Pancreatic enzymes to aid digestion
Treatments for intestinal obstructions
Newer therapies include lung transplantation for patients with end-stage lung disease. The type of transplant done is usually a heart-lung transplant, or a double lung transplant. Not everyone is a candidate for a lung transplant. Discuss this with your doctor.
Cystic fibrosis (CF) is a genetic disease. This means that CF is inherited. A person will be born with CF only if two CF genes are inherited--one from the mother and one from the father. A person who has only one CF gene is healthy and said to be a carrier of the disease. A carrier has an increased chance of having a child with CF. This type of inheritance is called autosomal recessive. Autosomal means that the gene is on one of the first 22 pairs of chromosomes which do not determine gender, so that the disease equally affects males and females. Recessive means that two copies of the gene, one inherited from each parent, are necessary to have the condition. Once parents have had a child with CF, there is a one in four, or 25 percent chance with each subsequent pregnancy, for another child to be born with CF. This means that there is a three out of four, or 75 percent chance, for another child to not have CF.
The birth of a child with CF is often a total surprise to a family, since most of the time (in eight out of 10 families) there is no previous family history of CF. Many autosomal recessive conditions occur this way. Since both parents are healthy, they had no prior knowledge that they carried the gene, nor that they passed the gene to their baby at the same time.
Genes are founds on structures in the cells of our body called chromosomes. There are normally 46 total, or 23 pairs of two chromosomes in each cell of our body. The seventh pair of chromosomes contains a gene called the CFTR (cystic fibrosis transmembrane regulator) gene. Mutations or errors in this gene are what cause CF. This gene is quite large and complex. Over 1,000 different mutations in this gene have been found which cause CF.
The risk for having a sporadic mutation in the gene for CF depends on your ethnic background (for persons without a family history of CF):
Risk of CF mutation
Risk of child with CF
1 in 29
1 in 2,500-3,500
1 in 46
1 in 4,000-10,000
1 in 65
1 in 15,000-20,000
1 in 90
1 in 100,000
Testing for the CF gene can be done from a small blood sample or from a cheek swab, which is a brush rubbed against the inside of your cheek to obtain cells for testing. Laboratories generally test for the most common mutations.
There are many people with CF whose mutations have not been identified. In other words, all of the genetic errors that cause the disease have not been discovered. Because not all mutations are detectable, a person can still be a CF carrier even if no mutations were found by carrier testing.
Testing for the CF gene is recommended for anyone who has a family member with the disease, or whose partner is a known carrier of CF or affected with CF.
The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.
Running the 26-mile Boston marathon is not easy for even conditioned runners. For marathoner Mark Buschle of Fort Thomas, Ky., finishing the race will be a particularly meaningful accomplishment.
Researchers in the Center for Regenerative Medicine at Massachusetts General Hospital and the Harvard Stem Cell Institute have taken a critical step toward a treatment for Cystic fibrosis and other fatal lung diseases.